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Abstract
Physico-chemical properties of the mutations G34R, P39L and E41K in the N-terminal do-
main of human heat shock protein B1 (HspB1), which have been associated with hereditary
motor neuron neuropathy, were analyzed. Heat-induced aggregation of all mutants started
at lower temperatures than for the wild type protein. All mutations decreased susceptibility
of the N- and C-terminal parts of HspB1 to chymotrypsinolysis. All mutants formed stable
homooligomers with a slightly larger apparent molecular weight compared to the wild type
protein. All mutations analyzed decreased or completely prevented phosphorylation-
induced dissociation of HspB1 oligomers. When mixed with HspB6 and heated, all mutants
yielded heterooligomers with apparent molecular weights close to ~400 kDa. Finally, the
three HspB1 mutants possessed lower chaperone-like activity towards model substrates
(lysozyme, malate dehydrogenase and insulin) compared to the wild type protein, converse-
ly the environmental probe bis-ANS yielded higher fluorescence with the mutants than with
the wild type protein. Thus, in vitro the analyzed N-terminal mutations increase stability of
large HspB1 homooligomers, prevent their phosphorylation-dependent dissociation, modu-
late their interaction with HspB6 and decrease their chaperoning capacity, preventing nor-
mal functioning of HspB1.
Introduction
Small heat shock proteins (sHsp) form a large family of proteins ubiquitously expressed in
practically all kingdoms that play an important role in cellular homeostasis [1–4]. Monomers
of sHsp have a comparatively small molecular weight (12–43 kDa) and similar primary struc-
ture. They are composed of a conserved α-crystallin domain, a β-sandwich structure, consisting
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of 90–100 residues that is the hallmark of all proteins belonging to this family [2–5]. The
α-crystallin domain is flanked by N- and C-terminal regions that vary in length and amino
acid composition and are predicted to have little or no secondary structure. The α-crystallin
domain plays an important role in the formation and stabilization of sHsp dimers [6–8] which
are the building blocks of larger oligomeric assemblies that are typically formed by these pro-
teins. The C-terminal domain, and in particular the conserved IXI/V motif (detected in the pri-
mary structure of certain small heat shock proteins) can interact with the α-crystallin domain
of the same or neighboring sHsp monomer possibly modulating stability of dimers and/or the
oligomers [9–11]. It is believed that the flexible N-terminal domain exists in multiple environ-
ments and provides for formation of large oligomers of certain sHsp often containing more
than twenty subunits [10, 12].
The human genome encodes ten members of the sHsp family [13, 14] and certain members
of this family (HspB1, HspB5, HspB6 and HspB8) are ubiquitously expressed in practically all
human tissues [4, 15]. These proteins participate in a plethora of different functions. For in-
stance, they interact with, and pevent the aggregation of partially denatured proteins which are
accumulated after stress, during the course of aging [16] or due to improper protein folding
[17]. They can regulate the elimination of denatured proteins by activation of proteolysis in
proteasomes or autophagosomes [18]. Small heat shock proteins are also involved in regulation
of redox state and protect the cell against oxidative stress [19]. Certain members of the sHsp
family possess antiapoptotic activity [20, 21], regulate proliferation [22], stabilize the cytoskele-
ton [23, 24] and seem to be involved in the regulation of many other vital cellular processes.
Since these proteins participate in many different cellular processes, it is not surprising that
their mutations have been associated with different congenital diseases such as cataract, des-
min-related myopathy, cardiomyopathy, distal hereditary motor neuropathy and Charcot-
Marie-Tooth disease [25–27]. In particular, about twenty mutants of HspB1 [25–27] are associ-
ated with distal hereditary motor neuropathy and/or type II Charcot-Marie-Tooth disease. The
molecular mechanisms underlying development of these diseases in relation to the mutations
in HspB1 remain poorly understood. This justifies a detailed investigation of the structure and
properties of the different congenital HspB1 mutants. These types of investigations were
previously performed on purified HspB1 carrying disease associated point mutations in the
α-crystallin domain [28–30] and in the C-terminal region [31]. At the same time mutations of
HspB1 in the N-terminal domain that are associated with hereditary motor neuron diseases
were not analyzed in detail until now. This paper deals with the investigation of some proper-
ties of G34R, P39L and E41K mutants of HspB1 associated with type II Charcot-Marie-Tooth
diseases [32] or distal hereditary motor neuropathy [33]. Clinically these mutations result in
different manifestations of disease. The G34R and E41K are associated with distal hereditary
motor neuropathy (dHMN), whereas mutation P39L is associated with either type II Charcot-
Marie-Tooth disease or dHMN. For mutations G34R and P39L the first symptoms of the dis-
ease were detected rather late (more than 50 years) as opposed to childhood (less than 10
years) for the E41K mutation and severity of these symptoms were either mild or intermediate
[32, 33]. In order to begin to understand the molecular mechanisms underlying these diseases
we investigated the physico-chemical properties of these three HspB1 mutants.
Experimental Procedures
Cloning and expression of recombinant wild type HspB1 and its N-
terminal mutants
cDNA of human wild type HspB1 in pET23b [34] was used for obtaining all N-terminal mu-
tants. Molecular constructs encoding N-terminal mutants of HspB1 were prepared by Eurogen
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(Moscow) and cloned into pET23b vector at NdeI and XhoI sites. The integrity of the different
HspB1 constructs was confirmed by DNA sequencing.
Expression of the wild type HspB1 and its N-terminal mutants was performed by exploiting
the leaky regulation of the T7 promoter in the Escherichia coli BL21 (DE3) pLysS strain [35].
Briefly, transformed bacteria were grown in 3-fold Luria-Bertani (LB) media at 37°C for 6–8 h
followed by growing overnight at 30°C. Bacterial cells were collected by centrifugation and sub-
jected to sonication and ammonium sulfate fractionation (0–40% saturation) as described pre-
viously [34]. Further purification was achieved by ion-exchange chromatography using HiTrap
Q (HP) column, followed by size exclusion chromatography on Superdex 200 column [34].
Protein preparations were concentrated by ultrafiltration, dialyzed against buffer B (20 mM
Tris/acetate, pH 7.6, containing 10 mMNaCl, 0.1 mM phenylmethane sulfonylfluoride
(PMSF), 0.1 mM EDTA and 1 mM dithiothreitol (DTT)), aliquoted and stored at -20°C.
The double mutant of HspB6 containing the substitutions C46S/E116C was expressed and
purified as described earlier [36].
Fluorescence spectroscopy
Intrinsic Trp fluorescence of the wild type HspB1 and its N-terminal mutants was measured at
25°C in buffer F (20 mMHEPES/NaOH pH 7.5, containing 100 mMNaCl and 2 mM DTT) at
a protein concentration equal to 0.1 mg/ml. Fluorescence spectra were measured using an exci-
tation wavelength of 295 nm (slit width 5 nm) and recorded in the range of 300–400 nm (slit
width 5 nm) on Varian Cary Eclipse spectrofluorometer.
Interaction with the fluorescent environment probe bis-ANS was analyzed by titration of
the different proteins (0.1 mg/ml) in buffer FF (50 mM phosphate (pH 7.5) containing 100
mMNaCl and 15 mM β-mercaptoethanol (ME)) with increasing amount of a stock solution of
bis-ANS (360 μM in buffer FF). Fluorescence was measured using an excitation wavelength of
385 (slit width 2.5 nm) and an emission wavelength of 495 nm (slit width 5 nm). All measure-
ments were performed at 25°C or 37°C. By recording the dependence of fluorescence upon the
total concentration of bis-ANS, we determined the apparent binding constant and the number
of bis-ANS-binding sites [37].
Heat-induced aggregation assays
The heat-induced increase of light scattering was measured in buffer F at a protein concentra-
tion of 0.3 mg/ml. In this case the protein samples were heated in the range of 20–85°C with a
rate of 1°C/min. The cells were illuminated at 340 nm (slit width 2.5 nm) and the signal was re-
corded at 340 nm (slit width 2.5 nm) on Varian Cary Eclipse spectrofluorometer.
Limited chymotrypsinolysis
Limited proteolysis was performed in buffer P (20 mM Tris/acetate pH 7.6, containing 10 mM
NaCl and 14 mMME) at 25°C. The wild type HspB1 and its N-terminal mutants (0.5 mg/ml)
were incubated with Nα-tosyl-L-lysine chloromethyl ketone-treated chymotrypsin (Sigma) at a
weight ratio substrate/chymotrypsin equal to 1000:1 for 0–180 min. The reaction was stopped
by the addition of PMSF and the resultant products were analyzed by sodium dodecylsulfate
polyacrylamide gel electrophoresis (SDS PAGE) [38]. The rate of proteolysis was determined
by plotting the negative logarithm of the ratio (St/S0), (where St and S0 are intensity of bands
corresponding to uncleaved HspB1 at a given and at zero time respectively), against time.
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Analysis of the quaternary structure
Two methods were used for investigation of the quaternary structures of the different HspB1
constructs. Dynamic light scattering (DLS) experiments were performed with 633 nm radiation
using a Zetasizer Nano (Malvern) in DLS buffer (20 mMHEPES/NaOH, pH 7.6, 100 mM
NaCl, 2 mMDTT) at 25°C and a protein concentration of 0.3 mg/ml. Each measurement lasted
for 15 s and was repeated 10 times and this cycle of measurement was repeated 10 times thus
providing accumulation of 100 measurements. The calculations were performed with the Zeta-
sizer software provided by the vendor using the intensity distributions for all
subsequent evaluations.
Alternatively the quaternary structure was analyzed by means of size
exclusion chromatography.
In this case 150 μl of sample containing variable quantities of protein (10–120 μg) were
loaded on Superdex 200 HR 10/30 column equilibrated with buffer S (20 mM Tris/acetate pH
7.6, containing 150 mMNaCl, 0.1 mM EDTA, 0.1 mM PMSF and 15 mMME). Chromatogra-
phy was performed at room temperature and at a flow rate of 0.5 ml/min. The column was cali-
brated with the protein standards thyroglobulin (669 kDa), ferritin (440 kDa), rabbit skeletal
muscle pyruvate kinase (240 kDa), rabbit skeletal muscle glyceraldehyde-3-phosphate dehy-
drogenase (136 kDa), bovine serum albumin (68 kDa), ovalbumin (43 kDa), chymotrypsino-
gen (25 kDa) and RNAse (13.7 kDa).
HspB1 phosphorylation
Constitutively active MKK6 protein kinase was incubated with p38 protein kinase for 1 h at
37°C in buffer Ph (25 mMHEPES/NaOH, 25 mM β-glycerophosphate, pH 7.5 containing
2 mM DTT, 20mMMgCl2 and 400 μM of ATP). MAPKAP kinase 2 was added to the incuba-
tion mixture and incubation at 37°C was continued for another hour. The mixture of activated
protein kinases was then divided into four parts and mixed with the wild type HspB1 or the
G34R, P39L and E41K mutants each at a final concentration of 0.7 mg/ml. The phosphoryla-
tion reactions were incubated at 37°C. At various times a sample was taken and the reaction
was stopped either by the addition of EDTA up to the final concentration of 5 mM (for size-
exclusion chromatography) or by addition of urea up to the final concentration of 4 M (for
urea gel electrophoresis). The extent of HspB1 phosphorylation was determined by quantita-
tive urea-gel electrophoresis [39, 40]. The location of the sites of phosphorylation was deter-
mined by means of mass-spectroscopy performed on tryptic peptides of unphosphorylated and
completely phosphorylated samples of the wild type HspB1 or its N-terminal mutants. The
composition of certain peptides obtained after chymotrypsnolysis was determined by tandem
mass-spectroscopy performed on Ultraflex Extreme BRUKER mass spectrometer.
Formation of heterooligomeric complexes of HspB1 and HspB6
Two different methods were used for analysis of the formation of heterooligomeric complexes
between HspB1 and HspB6. In the first case isolated HspB1 (wild type or an N-terminal mu-
tant) and isolated wild type HspB6 were preincubated alone for 30 min at 37°C in the presence
of 15 mM DTT in order to reduce their thiol groups. Thereafter the different HspB1 constructs
and the wild type HspB6 were mixed in buffer S so that the final concentration of each protein
was equal to 0.5 mg/ml. The mixture was divided into two parts and one part was incubated for
1 h on ice where exchange of sHsp subunits is very slow. The second part was incubated at
42°C for 1 h providing for effective subunit exchange. Each sample was loaded on Superdex
200 HR 10/30 column equilibrated with buffer S and operated at a rate of 0.5 ml/min at room
Mutations in N-Terminal Domain of HspB1 Associated with Neuropathies
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temperature. 400 μl fractions were collected and their protein composition was determined by
SDS PAGE [38].
Alternatively disulfide crosslinking was used for the analysis of the HspB1–HspB6 interac-
tion. In this case we used the double mutant of HspB6 (C46S/E116C) lacking natural Cys resi-
due in the N-terminal domain and containing a single Cys residue in position homologous to
that of Cys137 in HspB1 [36]. Reduced samples of the wild type HspB1 (or its N-terminal mu-
tants) were mixed with reduced Cys-mutant of HspB6 so that the final concentration of each
protein was 30 μM per monomer. Isolated proteins or their mixture were incubated for 1 h at
42°C followed by dialysis against 50 mM Tris/HCl pH 7.4, containing 50 mM KCl, 1 mM
MgCl2, 0.1 mM PMSF performed at 4, 15 or 37°C. After dialysis the protein samples were
mixed with SDS sample buffer lacking ME and subjected to SDS PAGE in the absence of ME.
Chaperone-like activity
Hen egg white lysozyme, porcine mitochondrial malate dehydrogenase (MDH) or porcine in-
sulin were used as model substrates for the evaluation of the chaperone-like activity. In the case
of lysozyme all experiments were performed in buffer L (50 mM potassium phosphate pH 7.4,
0.1 mM EDTA, 50 mMNaCl) at 37°C and at a final concentration of lysozyme equal to 0.14
mg/ml. The lysozyme was freshly prepared by dissolving in 40 mM potassium phosphate pH
4.0 containing 0.1 mM EDTA and subjecting to centrifugation (14.000 g, 10 min). The assay
mixture containing buffer L and different quantities of HspB1 or its mutants were preincubated
for 10 min at 37°C in the presence of 20 mMDTT in order to ensure reduce thiol groups of
this sHsp. The assay was started by the direct addition of lysozyme. The aggregation of reduced
lysozyme at 37°C was followed by measuring the optical density at 340 nm using an Ultrospec
3100 Pro spectrophotometer.
All experiments with MDH were performed in buffer M (10 mM sodium phosphate pH 7.4,
2 mM DTT) at 42°C and at the final concentration of MDH equal to 0.2 mg/ml and variable
concentrations of different species of HspB1. Heat-induced aggregation of MDH was followed
by measuring optical density at 340 nm on Ultrospec 3100 Pro spectrophotometer.
All experiments with insulin were performed by using buffer I (50 mM potassium phos-
phate pH 8.5, 100 mMNaCl). The incubation mixture contained 170 μl of buffer I, 100 μl of
buffer B containing different quantities of HspB1 (or its mutants) and 15 μl of 400 mM DTT.
The incubation mixture was preincubated at 37°C for 10 min and reaction was started by addi-
tion of insulin dissolved in 2.5% acetic acid up to the final concentration 0.15–0.30 mg/ml. Re-
duction-induced aggregation of insulin was followed by measuring the optical density at 340
nm on Ultrospec 3100 Pro spectrophotometer.
Results
Isolation of the wild type HspB1 and its N-terminal mutants
The recombinantly expressed WT HspB1 and the three N-terminal mutants could all be readily
purified from the soluble fraction of the E. coli lysate, where none constructs yielded inclusion
bodies (data not shown). The purification procedure resulted in homogeneous preparations of
the untagged proteins (Fig 1), with a yield of 50–60 mg per 1 l of growth media for each.
Spectral properties and thermal stability of HspB1 and its mutants
The absorbance spectra of all analyzed proteins were practically identical (Fig 2A). The fluores-
cence spectra of all analyzed proteins had a similar shape with a broad maximum located at
about 350 nm (Fig 2B). At the same time the amplitude of Trp fluorescence of E41K mutant
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was about 25–30% lower than that of any other mutants and of the wild type protein (Fig 2B).
This is likely due to replacement of the negatively charged glutamic acid by a positively charged
lysine in the immediate vicinity of Trp42. Thus, the point mutations analyzed do not induce
dramatic changes in the optical properties of HspB1.
The temperature-induced aggregation of HspB1 and its mutants was analyzed by recording
the light scattering upon heating from 20 to 85°C. As reported earlier [41, 42], heating is ac-
companied by HspB1 aggregation and increase of light scattering followed by decrease of light
scattering which can be due either to the change of density, shape or refractive index of
Fig 1. SDS PAGE analysis of the final preparation of the wild type HspB1 and its N-terminal mutants. About 3 μg of each protein was loaded into each
track. The positions of the protein markers (track M) and their molecular weight (in kDa) are marked by lines.
doi:10.1371/journal.pone.0126248.g001
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aggregating oligomers. The aggregation started at about 76°C for the wild type HspB1, at about
73°C for the G34R and P39L mutants, and at 62–63°C for E41K (Fig 3). Moreover, the intensity
of light scattering of all mutants at elevated temperatures was higher than that of the wild type
protein, suggesting a more pronounced aggregation. The data presented indicate that the N-
terminal mutants are more sensitive to heating than the wild type HspB1.
Limited chymotrypsinolysis
Limited proteolysis was used for further analysis of the structure of HspB1 and its N-terminal
mutants. Even short incubation of the wild type HspB1 with chymotrypsin (weight ratio
HspB1/chymotrypsin equal to 1000/1) was accompanied by accumulation of a series of protein
bands with apparent molecular weight of 25, 23 and 21 kDa on SDS PAGE (Fig 4A). Incuba-
tion for two hours led to the complete disappearance of the band corresponding to intact
uncleaved wild type HspB1 (Fig 4A). At the same time all N-terminal mutants were much
more resistant to chymotrypsinolysis and even after prolonged (3 h) incubation remained par-
tially uncleaved (Fig 4B and S1 Fig). The rate at which the band of intact protein diminished
was nearly the same for all analyzed mutants and much lower than that for the wild type
HspB1 (Fig 4C). Mass spectroscopic analysis revealed that the peptide bonds at Phe8, Phe19,
Phe29, Phe33, Trp45 as well as at Leu77 and Phe 185 are most susceptible to chymotrypsinoly-
sis (Fig 4D). As indicated on Fig 4A and 4B initial stages of chymotrypsinolysis are accompa-
nied by truncation of only short peptides of HspB1 thus meaning that aromatic residues
located in the very N-terminal or in the very C-terminal part of HspB1 are the primary sites of
chymotrypsinolysis. Thus, the data presented show that the point mutations G34R, P39L and
E41K inhibit chymotrypsinolysis in the N-terminal part (residues 8, 19, 29 and 33) and/or in
the C-terminal part (residue 186) of HspB1. This effect can be probably explained by muta-
tion-induced protection of certain parts of HspB1 monomer inside of large oligomers formed
by this protein or, alternatively, an increase in the stability of oligomeric species which are less
susceptible to proteolysis.
Fig 2. Absorbance (A) and fluorescence (B) spectra of the wild type HspB1 and its N-terminal mutants. Absorption and fluorescence spectra were
recorded in buffer F (20 mM HEPES/NaOH pH 7.5, containing 100 mMNaCl and 2 mMDTT) at a protein concentration equal to 0.1 mg/ml. Fluorescence
spectra were measured using an excitation wavelength of 295 nm (slit width 5 nm) and recorded in the range of 300–400 nm (slit width 5 nm). The black
dotted line in panel B indicates the fluorescence spectrum of buffer.
doi:10.1371/journal.pone.0126248.g002
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Quaternary structure of HspB1 and its N-terminal mutants
In size-exclusion chromatography, the wild type HspB1 was eluted as a single peak with an ap-
parent molecular weight of ~530 kDa. The position of the protein peak was practically inde-
pendent on the quantity of protein loaded on the column (Fig 5A). At low protein loading
concentration, positions of the main peaks of G34R and E41K mutants were similar to that of
the wild type protein, corresponding to an apparent molecular weight of 530–560 kDa (Fig 5B
and 5D). When the quantity of protein loaded on the column was increased the peak of both
mutants was shifted towards smaller elution volumes and their apparent molecular weight be-
came equal to~740 kDa for G34R and to ~600 kDa for E41K mutants. The apparent molecular
weight of P39L mutant was independent on the quantity of protein loaded on the column and
was close to 740 kDa (Fig 5C). These results were further supported by dynamic light scattering
on the purified proteins at 0.3 mg/ml. The size of particles formed by the wild type HspB1 was
slightly smaller than that of practically all analyzed mutants but the polydispersity of all protein
samples analyzed was very similar (Table 1). Thus, the presented data indicate that all mutants
Fig 3. Temperature dependent changes of the light scatteringmeasured at 340 nm of the wild type HspB1 (1) and the G34R (2), P39L (3) and E41K
(4) mutants. Protein samples (0.3 mg/ml) in buffer F (20 mM HEPES/NaOH pH 7.5, containing 100 mMNaCl and 2 mMDTT) were heated with a rate of 1°C/
min in the range of 20–85°C. The data presented are mean values of four measurements with error bars corresponding to standard deviation.
doi:10.1371/journal.pone.0126248.g003
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form stable oligomers with a size slightly larger than that of the wild type protein or have
higher tendency to self-association than the wild type HspB1.
Phosphorylation of HspB1 and its mutants
Human HspB1 can be phosphorylated by MAPKAP kinase 2 at three sites in the N-terminal
region: Ser15, Ser78 and Ser82 [43]. Therefore a priori the mutations of the N-terminal domain
might affect HspB1 phosphorylation. The wild type HspB1 and its N-terminal mutants were
phosphorylated by MAPKAP kinase 2 and the extent of phosphorylation was determined by
means of quantitative urea-gel electrophoresis (Fig 6). Under the conditions used incorpo-
ration of phosphate leads to an increase in electrophoretic mobility and therefore the triple
phosphorylated HspB1 sample possesses the highest mobility, whereas species containing one
or two mole of phosphate per mole of protein possess intermediate mobility [40]. Sometimes
(especially in the case of P39L and E41K mutants) we observed additional bands with electro-
phoretic mobilities intermediate between those of mono-, di- and triphosphosphorylated sam-
ples of HspB1 (Fig 6). These bands seem to originate from incomplete dissociation of
Fig 4. Limited chymotrypsinolysis of HspB1 and its N-terminal mutants. (A) and (B) SDS PAGE analysis of samples obtained after chymotrypsinolysis
of the wild type HspB1 (A) and its G34R (B) mutant. Time of proteolysis (min) is indicated above each track. The positions of the protein markers and their
molecular weight (in kDa) are indicated by lines. (C) Determination of the apparent rate constant of primary chymotrypsimolysis, as manifested by the
intensity decrease of the intact protein band for the wild type HspB1 (1) and its G34R (2), P39L (3) and E41K (4) mutants. The data presented are mean
values of five independent measurements with error bars corresponding to standard error of the mean. (D) Location of the most susceptible sites of
chymotrypsinolysis in the structure of HspB1 and the cleavage products accumulated at initial stages of chymotrypsinolysis.
doi:10.1371/journal.pone.0126248.g004
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oligomers of mutated HspB1 (discussed below). Prolonged incubation of HspB1 with MAP-
KAP kinase 2 resulted in incorporation of three moles of phosphate per mole (Fig 6B) and the
rate of phosphorylation of G34R and E41K was similar to the rate of phosphorylation of the
wild type protein, whereas the rate and extent of phosphorylation of P39L was slightly lower
(Fig 6B).
Phosphorylation catalyzed by MAPKAP kinase 2 induces the dissociation of large oligomers
and accumulation of small oligomers (dimers or tetramers) of the wild type HspB1 [44]. Partial
Fig 5. Size-exclusion chromatography of the wild type HspB1 (A) and its G34R (B), P39L (C), and E41K (D) mutants performed in buffer S (20 mM
Tris/acetate pH 7.6, containing 150mMNaCl, 0.1 mM EDTA, 0.1 mM PMSF and 15mMME) on a Superdex 200 column at room temperature. 150 μl of
sample containing variable quantities of protein (10–120 μg) were loaded on the column and eluted at a flow rate of 0.5 ml/min. Normalized elution profiles
obtained after loading on the column 10 (dotted lines), 30 (dash-dotted lines), 60 (dashed lines) and 120 (solid lines) μg of protein are presented.
doi:10.1371/journal.pone.0126248.g005
Table 1. Size (particle diameter D and polydispersity Pdi) of homooligomers of the wild type HspB1
and its N-terminal mutants as determined by dynamic light scattering.
Proteins D nm ± s.d. (intensity distribution) Pdi ± s.d.
Wild type HspB1 16.72 ± 0.94 0.336 ±0.133
G34R 20.97 ± 0.40 0.309 ± 0.035
P39L 21.37 ± 1.14 0.311 ± 0.014
E41K 19.36 ± 0.31 0.309 ± 0.076
doi:10.1371/journal.pone.0126248.t001
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Fig 6. Phosphorylation of the wild type HspB1 and its N-terminal mutants. (A) Urea PAGE of the wild
type HspB1 and its mutants after different times of incubation with activated MAPKAP kinase 2. Positions of
unphosphorylated, mono-, di- and triphosphorylated species are indicated by lines. The time of incubation is
indicated above each track. (B) Kinetics of phosphorylation determined by quantitative densitometry of urea
gel electrophoresis. --, wild type HspB1, -▲-G34Rmutant, -&-P39L mutant, -●-E41Kmutant. The data
presented are mean values of four independent measurements with error bars corresponding to standard
error of the mean.
doi:10.1371/journal.pone.0126248.g006
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dissociation of large oligomers of the wild type HspB1 is observed even after incorporation of
less than 1 mole phosphate per mole of HspB1 [30, 44] (S2 Fig). We analyzed the effect of
phosphorylation on the oligomeric structure of the wild type HspB1 and its N-terminal mu-
tants. As expected, phosphorylation up to 1.2–1.6 mole per mole of the wild type protein was
accompanied by complete dissociation of large oligomers and accumulation of only small olig-
omers of the wild type HspB1 (Fig 7). At equivalent phosphorylation levels the oligomeric state
of the N-terminal mutants was not changed and they remained in the form or large oligomers
(Fig 7). At phosphorylation levels exceeding 2 moles of phosphate per mole of protein we de-
tected only partial dissociation of large oligomers of G34R and E41K mutants, whereas large
oligomers of the P39L mutant remained practically unchanged (Fig 7 panels B, D and C respec-
tively). There is a possibility that the mutations affect the specificity of MAPKAP kinase 2 or
the other kinases present in the activating mixture and that other sites on HspB1 were phos-
phorylated leading to the observed results. However, this was disproved as mass-spectroscopy
analysis of tryptic peptides showed that the same sites were phosphorylated in the wild type
HspB1 and its P39L mutant (S3 Fig and S1 Table). Thus, the data presented indicate that the
Fig 7. Size-exclusion chromatography of the wild type HspB1 and its G34R, P39L and E41Kmutants before phosphorylation (black curves) and
with different levels of phosphorylation (blue and red curves) run at a flow rate of 0.5 ml/min in buffer S (20 mM Tris/acetate pH 7.6, containing 150
mMNaCl, 0.1 mM EDTA, 0.1 mM PMSF and 15mMME) on a Superdex 200 column at room temperature. The extent of phosphorylation, which was
determined by quantitative densitometry of urea PAGE gels, is indicated on each panel.
doi:10.1371/journal.pone.0126248.g007
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mutations in the N-terminal domain partially or completely prevent phosphorylation-induced
dissociation of large oligomers of HspB1.
Formation of heterooligomeric complexes of HspB1 with HspB6
The wild type HspB1 effectively interacts with HspB6 forming two types of heterooligomeric
complexes with apparent molecular weights of ~100 and ~300 kDa [29, 30, 45](Fig 8A and S4
Fig). The N-terminal mutants were also able to interact with HspB6. As in the case with the
wild type HspB1, this interaction was dependent on the temperature of incubation, and we ob-
served formation of heterooligomeric complexes only after preincubation of the mixture of
HspB1 mutants and HspB6 at elevated temperature (Fig 8B). Under the analyzed conditions
the N-terminal mutants formed only one type of heterooligomeric complex with HspB6 with
apparent molecular weight between 370–380 kDa for E41K and G34R mutants and 420 kDa
for P39L mutant (Fig 8B, S4 Fig).
Disulfide crosslinking was also used for investigation of the interaction of the wild type
HspB1 and its N-terminal mutants with HspB6. In this case we mixed HspB1 (and its mutants)
with the so-called Cys mutant of HspB6, containing a single Cys residue in a position homolo-
gous to that of Cys137 of HspB1 [36]. Mild oxidation leads disulfide crosslinking of Hsp mono-
mers within the homo- or heterooligomeric complexes. In preliminary experiments we failed
to detect any changes in kinetics of disulfide crosslinking of monomers inside of the wild type
HspB1 homooligomers or any of its N—terminal mutants (S5 Fig). At the same time disulfide
bridged heterodimers formed between HspB6 and any of the HspB1 N-terminal mutants were
accumulated more slowly than the corresponding heterodimers between HspB6 and the wild
type HspB1 (Fig 9). Qualitatively similar results were obtained if disulfide crosslinking was per-
formed at 4, 15 (data not presented) or 37°C. Thus the mutations in the N-terminal domain af-
fect either kinetics of subunits exchange or the probability of crosslinking HspB1 and HpsB6 in
heterooligomeric complexes.
Fig 8. Interaction of the wild type HspB1 (A) and its E41Kmutant (B) with the wild type HspB6 analyzed by means of size-exclusion
chromatography performed at room temperature on a Superdex 200 column.On each panel elution profiles of the isolated wild type HspB1 (blue line),
isolated E41Kmutant (green line) and isolated HspB6 (dark yellow line) are presented. The elution profiles of the mixture of the two proteins preincubated at
4 and 42°C are shown as black and red lines respectively. The protein composition of samples collected at positions marked by the numbered arrows is
presented in the insert. Positions of HspB1 (B1) and HspB6 (B6) are marked by lines.
doi:10.1371/journal.pone.0126248.g008
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Fig 9. Disulfide crosslinking of HspB1 and the Cysmutant of HspB6 inside heterooligomeric
complexes. (A) SDS PAGE analysis, performed under non-reducing conditions, of heterooligomeric
complexes formed between the Cys-mutant of HspB6 and the wild type HspB1 and its G34R, P39L and E41K
mutants. The positions of monomeric HspB6 (B6) and HspB1 (B1), disulfide crosslinked homodimers of
HspB1 (B1–B1) and crosslinked heterodimers of HspB1 and HspB6 (B1–B6) and of molecular weight
standards are indicated by arrows. Time of dialysis (h) is indicated above each track. (B) Ratio of the peak
corresponding to crosslinked HspB1-HspB6 (B1–B6) to that of crosslinked HspB1 (B1–B1) after dialysis for 4
h. The data presented are mean values of four independent measurements with error bars corresponding to
the standard error of the mean.
doi:10.1371/journal.pone.0126248.g009
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Chaperone-like activity
Three different model substrates, namely lysozyme, malate dehydrogenase (MDH) and insulin
were used for estimation of the chaperone-like activity of HspB1 and its N-terminal mutants.
Reduction of disulfide bonds is accompanied by denaturation and aggregation of lysozyme (Fig
10A). The wild type HspB1 delayed the appearance of light scattering aggregates of reduced ly-
sozyme by 20 minutes (Fig 10A). The chaperone-like activity of the P39L mutant was compara-
ble with that of the wild type protein, whereas the chaperone-like activity of G34R and
especially the E41K mutant was lower than that of the wild type HspB1.
Heating induces denaturation and aggregation of MDH and the wild type HspB1 retarded
aggregation of this model protein substrate (Fig 10B). Based on final absorbance the G34R and
E41K mutants were moderately less effective in retardation of MDH aggregation, whereas the
chaperone-like activity of P39L mutant with this model protein substrate was comparable to
that of the wild type protein.
Finally, in the case of reduction-induced aggregation of insulin we found that all N-terminal
mutants possessed lower chaperone-like activity than the wild type HspB1. With this model
protein substrate E41K mutant had the lowest chaperone-like activity followed by the P39L
and G34R mutants (Fig 10C).
The data presented indicate that as a rule the chaperone-like activity of the N-terminal mu-
tants is less than that of the wild type protein, however, the chaperone-like activity of N-termi-
nal mutants is dependent on the nature of model protein substrate and can be comparable with
that of the wild type protein with one model substrate and at the same time markedly smaller
in the case of another model protein substrate.
It is assumed that the chaperone-like activity is at least partially dependent on hydrophobic
interactions between small heat shock proteins and their protein substrates [2, 46, 47]. There-
fore it seems reasonable to compare hydrophobic properties of the wild type HspB1 and the
different N-terminal mutants. Titration with the environmental sensitive hydrophobic probe
bis-ANS is accompanied by a significant increase in fluorescence (Fig 11). Non-linear fitting of
the titration curves revealed no significant differences in the apparent binding constant or the
number of bis-ANS-binding sites, however the maximal intensity of fluorescence of the com-
plexes formed by bis-ANS and HspB1 mutants was larger than that of the complexes formed
by bis-ANS and the wild type HspB1 (Fig 11). This effect can be due to the change in the envi-
ronment of bis-ANS-binding sites in the wild type HspB1 and its N-terminal mutants. These
changes can be induced by replacement of neutral (G34) or negatively charged residues (E41)
by positively charged arginine or lysine in G34R and E41K mutants, respectively. At the same
time the data presented indicate that decreased chaperone-like activity of the N-terminal mu-
tants is not due to decrease in their hydrophobicity.
Discussion
The N-terminal domain of vertebrate small heat shock proteins is generally considered as
being poorly conserved at the sequence level and predicted to contain little or no secondary
structure [12]. This is reflected in available structures, in particular those from vertebrates for
which no full-length crystal structure exists [12]. At present, within this subphylum the 3D
structure is described only for the isolated α-crystallin domain with a few additional amino
acid residues on its N- and C-terminal ends [6–8, 48], while no full-length vertebrate sHsps
could be crystallized thus far. Despite the apparent lack of structure the N-terminal domain
plays an important role both in stabilization of oligomeric structure and in defining the chaper-
one-like activity of human sHsps [12, 49, 50]. This dual role can complicate detailed analysis of
different parts of the N-terminal domain in sHsp functioning. This complication was recently
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Fig 10. Chaperone-like activity of the wild type HspB1 and its N-terminal mutants with lysozyme (LYS)
(A), malate dehydrogenase (MDH) (B) and insulin (INS)(C) as model protein substrates. Aggregation of
denatured protein substrates was followed by recording the optical density at 340 nm. The curves labeled
LYS, MDH and INS correspond to aggregation of isolated protein substrates in the absence of HspB1,
whereas the curves labeledWT or by a mutant name correspond to aggregation in the presence of the
different HspB1 constructs. The concentration of lysozyme was equal to 0.14 mg/ml and the concentration of
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overcome by analysis of functional role of different parts of the N-terminal domain of human
HspB6 predominantly presented in the form of stable dimers [51].
Provisionally four different regions can be described in the N-terminal domain of HspB1
(Fig 12A). The first encompasses approximately 25 residues of the immediate N-terminus of
this sHsp, HspB6 and HspB8 and about 20 N-terminal residues in HspB2 and the two α-crys-
tallins (HspB4 and HspB5). This region is enriched in hydrophobic/aromatic and positively
charged residues and seems to be responsible for the interaction of sHsp with different protein
ligands. Mutations of certain residues or partial deletion of this region [51] were accompanied
by a decrease of chaperone-like activity. Deletion of the first 15 residues did not affect the
HspB1 and its mutants in this experiment was equal to 0.20 mg/ml respectively. The concentration of MDH
was equal to 0.20 mg/ml and that of the HspB1 variants was equal to 0.02 mg/ml. The concentration of insulin
was equal to 0.15 mg/ml and that of the HspB1 variants was equal to 0.03 mg/ml. Data are representative of
at least three independent experiments with error bars corresponding to the standard error of the mean.
doi:10.1371/journal.pone.0126248.g010
Fig 11. Titration of the wild type (WT) HspB1 and its N-terminal mutants with the environmental probe bis-ANS. Protein samples (0.1 mg/ml) in buffer
FF (50 mM phosphate (pH 7.5) containing 100 mMNaCl and 15 mM β-mercapthoethanol (ME)) were titrated with a stock solution of bis-ANS (360 μM in
buffer FF). Fluorescence was measured using excitation wavelength of 385 (slit width 2.5 nm) and an emission wavelength of 495 nm (slit width 5 nm). All
measurements were performed at 25°C. The titration curve of the buffer in the absence of any protein is marked as control. The data presented are mean
values of six independent measurements with error bars corresponding to standard deviation.
doi:10.1371/journal.pone.0126248.g011
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oligomeric structure of Chinese hamster Hsp27 (ortholog of human HspB1), whereas a dele-
tion of the first 23–30 N-terminal residues was accompanied by dissociation of large oligomers
of this protein [52]. Mutations in this region also affected the oligomeric structure of HspB5
[53].
The second region restricted to residues 26–41 of HspB1 (and HspB6) (Fig 12A and 12B),
contains a highly conserved sequence (that is found present in a subset of the vertebrate sHsp
family as well as in close related homologous in Drosophila melanogaster [51]). This region is
reported to possess a dual function and is able to inhibit the chaperone-like activity and at the
same time participates in self-association of HspB6 (and probably other sHsp’s) [51].
The third region corresponding to residues 42–59 of HspB1 and HspB6 (Fig 12) seems to be
important for stabilization of oligomeric structure of HspB1 [49] and for increased chaperone-
like activity of HspB6 [51]. The C-terminal part of this region restricted by residues 42–56 of
HspB1 (or residues 43–56 of HspB6, or residues 39–51 of HspB5) again participates in the in-
teraction of HspB5 and HspB6 with target proteins [50, 51] and in regulation of oligomeriza-
tion of small heat shock proteins tending to form large oligomers (like HspB1 and HspB5)
[57].
Fig 12. Sequence analysis of the N-terminal domain of different vertebrate sHsp homologues. (A) Multiple sequence alignment of the N-terminal
domain of sHsp from selected vertebrate species. Identified sequences corresponding to the N-terminal domain of human HspB1, HspB2, HspB4, HspB5,
HspB6 and HspB8 were aligned against their orthologues found in bovine, rodent, Xenopus and zebrafish with Muscle [54]. Using Jalview [55] the aligned
sequences were grouped based on their UniProt annotation and each group was colored using the ClustalX scheme. The commonly conserved sequence
motif, corresponding to residues 26–41 in HspB1, is darkly colored across the alignment. The P1 peptide insert and the residues corresponding to β2 of the
α-crystallin domain, as determined from available crystal structures, are highlighted below the alignment. (B) Sequence logo representation of the conserved
sequence motif. Residues are colored according to the ClustalX scheme. Numbering of the residues is according to the HspB1 sequence. The image was
initially created using weblogo 3 [56]. In both panels the position of the three mutated residues in HspB1 characterized here are highlighted by a black star.
doi:10.1371/journal.pone.0126248.g012
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Finally HspB1 contains a unique sequence, previously named P1 [49], that includes residues
59–77 (Fig 12). This region seems to play an important role in the formation of the large oligo-
mers of this sHsp [58]. Although the sequence of this region is poorly conserved when compar-
ing it to other vertebrate homologues, it appears rich in proline and in some species
alanine residues.
To date the functional characteristics of the different parts of the N-terminal domain of the
vertebrate sHsp have been determined either by truncation or deletion [51, 52, 57], by swap-
ping regions between different sHsp [58] or by replacing of certain residues of the N-terminal
domain by Cys followed by selective modification of the introduced Cys by electron paramag-
netic resonance probes [49]. However, to our knowledge the effect of single point mutations on
physico-chemical properties of HspB1 has not been systematically investigated.
The three congenital mutations characterized in this study all localize to the conserved re-
gion (Fig 12A and 12B). In particular Gly34 of human HspB1 is highly conserved being present
in five other vertebrate sHsp (HspB2, HspB4, HspB5, HspB6 and HspB8) (Fig 12) [26]. Pro39
of human HspB1 is less well conserved across this subset of sHsp, but is also found in the
equivalent position of human HspB2, HspB7 and HspB8 across the majority of species [26]
(Fig 12A). Finally, residue E41 of human HspB1, like Gly34, is also highly conserved across ho-
mologues [26] (Fig 12).
Mutations in this conserved region are accompanied by similar changes in the structure and
properties of HspB1. Indeed, all mutants form stable oligomers with the size slightly larger
than the corresponding oligomers of the wild type HspB1 (Fig 5, Table 1). The increased size of
the oligomers formed by the N-terminal mutants could be either due to an increased number
of subunits involved in the formation of these assemblies or due to an increased size of the olig-
omer the core of which is packed less densely because of the unusually folded N-terminal do-
mains of mutated HspB1. The last suggestion agrees with the data obtained by limited
proteolysis. All mutants are less susceptible to proteolysis than the wild type HspB1 (Fig 4).
Taking into account that the largest part of the sites most susceptible to chymotrypsinolysis are
located in the N-terminal domain of HspB1 (Phe8, Phe19, Phe29, Phe33 and Trp45) we can
hypothesize that mutations G34R, P39L and E41K somehow stabilize the structure of the flexi-
ble and therefore highly susceptible to proteolysis N-terminal domain of HspB1. It is postulat-
ed that the N-terminal domains are located in the center of sphere formed by large oligomers
of αB-crystallin and participate in stabilization of this structure [12]. It is probable that muta-
tions in the N-terminal domain of HspB1 enhance the interaction between N-terminal do-
mains of neighbor subunits thus stabilizing the oligomeric structure of large oligomers of
HspB1.
It is well known that the oligomeric structure of HspB1 is delicately regulated by phosphory-
lation of three sites (Ser15, Ser78, Ser82) located in the N-terminal domain and in the begin-
ning of α-crystallin domain [43, 44, 52]. Incorporation of less than 1 mole of phosphate per
mole of the wild type HspB1 is accompanied by partial or even complete dissociation of large
oligomers and accumulation of small oligomers with apparent molecular weight ~90 kDa (Fig
7, S2 Fig). At the same time phosphorylation even up to more than 2.0 mole phosphate per
mole of protein resulted in incomplete dissociation of large oligomers formed by G34R an
E41K mutants and did not induce any significant changes in the oligomeric structure of P39L
mutant (Fig 7). Thus, mutations in the N-terminal domain counteract the phosphorylation-in-
duced dissociation of large oligomers which is assumed to be of great importance for effective
functioning of HspB1 [49, 52]. This effect can be due to the increased interaction of the N-ter-
minal domains between neighboring monomers, and hiding of these domains inside of the
large HspB1 oligomers. In this respect it is worthwhile to mention that mutations P39C and
E41C of the so-called 3D phosphomimicking mutant of HspB1 was accompanied by shifting
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equilibrium between small and large oligomers towards large oligomer of HspB1 [49]. Thus,
the mutations G34R, P39L and E41K analyzed here partially or completely prevent dissociation
of large oligomers induced by phosphorylation and to different extents increase the stability of
these high molecular weight species.
Small heat shock proteins are able to form different heterooligomers with properties proba-
bly different from those of corresponding homooligomers [19, 59]. The wild type HspB1
formed two type of complexes with HspB6 with apparent molecular weights of ~100 and 300
kDa (Fig 8)[34, 45]. All N-terminal mutants of HspB1 were also able to form heterooligomeric
complexes with HspB6, however in this case we detected only one type of complex, with an ap-
parent molecular weight of ~400 kDa (Fig 8, Supplemental material S3 Fig). We also detected
retardation of disulfide crosslinking of the so-called Cys mutant of HspB6 and the N-terminal
mutants compared to those formed with the wild type HspB1 (Fig 9). Mutations in the
N-terminal domain of HspB1 appear to affect the stability of the dimer interface in the hetero-
dimers. The nature of this instability manifested by a change in subunit turnover or the in-
creased possibility of forming another interface register at the dimer interface cannot be
ascertained from the results presented.
By using three different model protein substrates we found that as a rule the wild type
HspB1 possessed higher chaperone-like activity than any of the N-terminal mutants, however
the difference in the chaperone-like activity was dependent on the nature of the model protein
substrate (Fig 10). It is supposed that reversible dissociation/association of HspB1 oligomers
plays an important role in its chaperone like activity [49]. Therefore the increased stability of
the oligomers formed by the N-terminal mutants can modulate chaperone-like activity of
HspB1. Moreover, the N-terminal domain contains several substrate-binding sites and there-
fore mutations of certain sites can differently affect chaperone-like activity with different
model substrates, a phenomenon that was previously described [51]. It is worthwhile though to
mention that the decrease of chaperone-like activity of the N-terminal mutants of HspB1 mu-
tants is not due to a decrease of their hydrophobicity (Fig 11).
In summary, we conclude that the mutations of the N-terminal domain associated with he-
reditary motor neuron diseases likely stabilize the oligomeric assembly in vitro and therefore
decrease or completely prevent phosphorylation-induced dissociation of large oligomers of
HspB1 and modify its interaction with HspB6. In addition these mutations decrease the chap-
erone-like activity. It is possible that one or these effects, or a combination of thereof, alters the
interaction of HSPB1 with proteins in the cell possibly leading to long term motor
neuron diseases.
Supporting Information
S1 Fig. SDS-electrophoresis of the samples obtained after limited chymotrypsinolysis of the
wild type HspB1 (A) and its P39L (B) and E41K (C) mutants. Time of proteolysis (min) is in-
dicated above each track. The positions of the protein markers and their molecular weight (in
kDa) are indicated by lines. Representative results of five independent experiments
are presented.
(PDF)
S2 Fig. Size-exclusion chromatography of the wild type HspB1 and its G34R, P39L and
E41K mutants before phosphorylation (black curves) and after low levels of phosphoryla-
tion (red curves). The extent of phosphorylation is indicated on each panel.
(PDF)
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S3 Fig. MS spectra of tryptic peptides ALS78R (A), GPS15WDPFR (B) and QLS82SGVSEIR
(C) before and after phosphorylation of the wild type (WT) or P39L (P39L) mutant of
HspB1.
(PDF)
S4 Fig. Interaction of the wild type HspB1 and its G34R and P39L mutants with the wild
type HspB6 analyzed by means of size-exclusion chromatography. On each panel the elution
profiles of isolated wild type HspB1 (blue line), isolated mutants (green line) and isolated
HpsB6 (dark yellow line) are presented. Elution profile of the mixture of two proteins preincu-
bated at 4 and 42°C are shown as black and red lines respectively.
(PDF)
S5 Fig. Disulfide crosslinking of the wild type HspB1 (A) and its G34R (B), P39L (C) and
E41K (D) mutants. SDS-gel electrophoresis of the samples before oxidation and after dif-
ferent time of dialysis under non-reducing conditions. The time of dialysis (hours) is indicat-
ed above each track. The positions of the protein markers and their molecular weight (in kDa)
are indicated by lines. Representative data of three independent experiments are presented.
(PDF)
S1 Table. Molecular weights of tryptic peptides of the wild type HspB1 and its P39L mutant
before and after phosphorylation. The values in brackets indicate calculated molecular
weights of unphosphorylated and phosphorylated peptides.
(PDF)
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